预测胃非治愈性内镜黏膜下剥离术后残留肿瘤:西方背景下eCura系统的验证与改良:W-eCura评分
这项回顾性多中心 multinational 研究基于19个西方中心前瞻性收集的登记数据,分析314例非治愈性胃ESD,验证eCura系统预测淋巴结转移的准确性并创建改良W-eCura评分。eCura各组间LNM风险显著不同(AUC-ROC 0.900,95%CI 0.852-0.949),W-eCura的AUC-ROC为0.916(95%CI 0.870-0.961;p=0.012),显著高于原eCura。结论认为eCura系统可用于西方国家胃高风险切除后LNM风险分层,新评分可能进一步减少不必要手术。
要点
- 314例非治愈性胃ESD中72%为高风险切除,28%为局部风险切除。
- 接受手术的高风险切除患者中25%有壁残留病变,15%手术标本有淋巴结转移。
- W-eCura评分预测LNM的AUC-ROC为0.916,显著高于原eCura的0.900(p=0.012)。
核心结论
- eCura评分系统可应用于西方国家,对胃高风险切除后淋巴结转移风险进行分层。
- 作者提出一种新评分(W-eCura),可能进一步减少不必要的手术。
研究设计与样本
- 回顾性多中心跨国研究,基于19个西方中心前瞻性收集的登记数据。
- 纳入接受手术或至少一次随访内镜的患者,共分析314例非治愈性胃ESD。
主要发现
- 314例非治愈性胃ESD中,72%为高风险切除,28%为局部风险切除。
- 接受手术的高风险切除患者中,25%有壁病变,15%手术标本有淋巴结转移。
- eCura各组间淋巴结转移风险显著不同,AUC-ROC为0.900(95%CI 0.852-0.949)。
- W-eCura预测淋巴结转移的AUC-ROC为0.916(95%CI 0.870-0.961;p=0.012),显著高于原eCura。
- 垂直切缘阳性、淋巴管侵犯和较年轻年龄与手术标本中壁残留病变风险较高相关。
关键数值与推荐
- eCura系统预测淋巴结转移的AUC-ROC为0.900(95%CI 0.852-0.949)。
- W-eCura评分预测淋巴结转移的AUC-ROC为0.916(95%CI 0.870-0.961;p=0.012)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the risk factors for lymph node metastasis (LNM) after a non-curative (NC) gastric endoscopic submucosal dissection (ESD) and to validate and eventually refine the eCura scoring system in the Western setting. Also, to assess the rate and risk factors for parietal residual disease. DESIGN: Retrospective multicentre multinational study of prospectively collected registries from 19 Western centres. Patients who had been submitted to surgery or had at least one follow-up endoscopy were included. The eCura system was applied to assess its accuracy in the Western setting, and a modified version was created according to the results (W-eCura score). The discriminative capacities of the eCura and W-eCura scores to predict LNM were assessed and compared. RESULTS: A total of 314 NC gastric ESDs were analysed (72% high-risk resection (HRR); 28% local-risk resection). Among HRR patients submitted to surgery, 25% had parietal disease and 15% had LNM in the surgical specimen. The risk of LNM was significantly different across the eCura groups (areas under the receiver operating characteristic curve (AUC-ROC) of 0.900 (95% CI 0.852 to 0.949)). The AUC-ROC of the W-eCura for LNM (0.916, 95% CI 0.870 to 0.961; p=0.012) was significantly higher compared with the original eCura. Positive vertical margin, lymphatic invasion and younger age were associated with a higher risk of parietal residual lesion in the surgical specimen. CONCLUSION: The eCura scoring system may be applied in Western countries to stratify the risk of LNM after a gastric HRR. A new score is proposed that may further decrease the number of unnecessary surgeries.
引用
- Morais R, Libanio D, Dinis Ribeiro M, et al. Predicting residual neoplasia after a non-curative gastric ESD: validation and modification of the eCura system in the Western setting: the W-eCura score. Gut. 2023. PMID: 37666656. doi:10.1136/gutjnl-2023-330804
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。